The president will impose a baseline 10% tariff on all countries, as well as higher levies on certain nations. Pharmaceutical ...

Provider groups and health systems warn tariffs will test healthcare’s fragile supply chain, threatening to create ...

Reduction-in-force notices went out Tuesday morning to employees across HHS. At FDA, OND director Peter Stein is departing as ...

Cellular Therapies and IDRx, crossed the $1 billion mark, a notable decrease from the six seen during the same period last ...

In his resignation letter, Marks cited disagreement with HHS Secretary Robert F. Kennedy Jr., who he said pushed ...

The delayed decision comes amid a major organizational shakeup that included the departure of top vaccine official Peter ...

Many HHS department heads and staff were unaware of plans to fire some 10,000 employees until they were publicly disclosed ...

Marks’ resignation leaves the field without a regulator many view as “integral” to its progress over the last decade.

More than three-quarters of private biotech investment tracked by BioPharma Dive between January and March was distributed ...

Artis BioSolutions joins a host of startups trying to improve development and manufacturing capacity for cutting-edge gene ...

The FDA will lose about 3,500 employees under the plans, although HHS said drug, medical device and food reviewers will not ...

Pluvicto can now be used before chemotherapy to treat a kind of metastatic prostate cancer, tripling the number of patients ...